Core Viewpoint - The company Beiqing Song (倍轻松) and its actual controller Ma Xuejun are under investigation by the China Securities Regulatory Commission (CSRC) for suspected information disclosure violations, following a significant drop in net profit and stock price [2][6]. Group 1: Investigation Details - Beiqing Song announced on December 25 that it and Ma Xuejun are being investigated for information disclosure violations [2][6]. - Following the announcement, the company's stock price plummeted, causing losses for many investors [7]. - Ma Xuejun sold 2.97% of the company's shares (255.26 million shares) for approximately 64.64 million yuan just one month before the investigation was announced, reducing his stake below 50% for the first time [8]. Group 2: Financial Misconduct - The investigation is not unexpected, as there have been ongoing issues with the company's internal controls and frequent fund occupation by Ma Xuejun [8]. - A self-examination revealed that from 2021 to 2022, Ma Xuejun occupied company funds through employee loans totaling 4.08 million yuan [3][9]. - The company also made early payments to suppliers, with 8 million yuan identified as funds occupied by Ma Xuejun [9]. - The total amount of funds occupied by Ma Xuejun was revised from 54 million yuan to 85.93 million yuan, with significant amounts transferred through related companies [9]. Group 3: Investor Compensation - Over 5,000 investors are concerned about how to protect their rights following the investigation [10]. - A pre-registration for investor compensation has begun, allowing those who bought shares before December 25, 2025, and sold or still hold them after December 26, 2025, to claim losses [10].

登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 12月25日晚，深圳市倍轻松（维权）科技股份有限公司（以下简称"公司"、"倍轻松"）发布公告，因公 司及实际控制人马学军先生涉嫌信息披露违法违规，根据《中华人民共和国证券法》《中华人民共和国 行政处罚法》等法律法规，中国证监会决定对公司及实际控制人马学军先生立案。上海市信本律师事务 所赵敬国律师（执业证号：13101200410820485）提示，于2025年12月26日之前买入且有持仓，无论在 2025年12月26日及之后是否卖出的受损投资者，或可通过"新浪股民维权平台"自愿登记索赔。（赵敬国 律师专栏） 此次被立案原因尚不清楚，但此前公司已经发布非经营性资金占用公告，此次立案调查或与前述事项有 关。2025年8月2日，经公司自查发现，公司实际控制人马学军以往年度存在通过员工借款方式、提前支 付供应商采购款方式形成的资金占用。2021年10月以来 ...

值得注意的是，就在此次立案告知书下达的一个月前，马学军刚刚完成了一笔股份转让。 根据倍轻松11月21日披露的《股东询价转让结果报告书》，马学军通过询价转让方式，减持了其持有的 公司股份255.26万股，占公司总股本的2.97%。 该次询价转让的价格为25.35元/股，据此计算，马学军通过此次转让套现金额约为6471万元。 此次权益变动后，马学军及其一致行动人持有倍轻松的股份比例从52.35%减少至49.38%，降至50%以 下，对于转让原因，公开信息显示为"出让方自身资金需求"。 与马学军在立案前夕完成大额套现形成对比的是，倍轻松另一位持股5%以上的股东汪荞青在立案前一 周选择了终止减持。 智通财经12月26日讯（记者 王碧微）在实控人完成大额股份转让一个月后，倍轻松（688793.SH）收到 了监管层的调查通知。 12月25日晚间，倍轻松披露公告，公司及实际控制人马学军于12月25日收到中国证监会下发的《立案告 知书》，因涉嫌信息披露违法违规，证监会决定对公司及马学军立案。 倍轻松方面在公告中表示，目前各项经营活动正常开展，在立案调查期间将积极配合相关工作。 财务数据显示，2025年前三季度，倍轻松实现营业 ...

Core Viewpoint - The company Beiqing Song (倍轻松) and its actual controller Ma Xuejun are under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, which has led to a significant drop in the company's stock price [1][3]. Group 1: Regulatory Investigation - On December 25, the CSRC issued a notice of investigation to Beiqing Song and Ma Xuejun for suspected information disclosure violations [1]. - The company stated that its business operations are currently normal and that it will actively cooperate during the investigation [2]. Group 2: Legal Issues - Beiqing Song is involved in a patent infringement lawsuit filed by Da Dong Electric Industrial Co., Ltd., seeking 10 million yuan in damages and the cessation of sales of the disputed products [2]. - The company indicated that the products in question are not core products and do not expect significant impact on daily operations [2]. Group 3: Financial Performance - For the first three quarters of 2025, Beiqing Song reported a revenue of 552 million yuan, a year-on-year decrease of 34.07%, and a net loss attributable to shareholders of 65.63 million yuan, a decline of 600.98% [8]. - As of June 30, 2025, the company had an undistributed profit loss of 41.20 million yuan, with total paid-in capital of 85.95 million yuan, indicating that the unrecouped losses exceeded one-third of the total paid-in capital [8]. Group 4: Shareholder Actions - One month prior to the investigation notice, Ma Xuejun sold 2.55 million shares, approximately 2.97% of the company, for about 64.71 million yuan, citing personal funding needs [5]. - In contrast, another major shareholder, Wang Qiaoqing, terminated a planned share reduction just a week before the investigation notice, expressing confidence in the company's long-term development [5]. Group 5: Financial Mismanagement - The company has faced scrutiny for previous financial mismanagement, including significant fund occupation by the actual controller, which was reported to be 85.93 million yuan after corrections [9]. - In 2024 alone, the actual controller's fund occupation through supplier channels reached 25.10 million yuan [10].

Core Viewpoint - The company Beiqing Song (倍轻松) is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, which has led to a significant drop in its stock price and raised concerns about its financial health and governance practices [1][2][11]. Group 1: Regulatory Issues - On December 25, the company and its actual controller, Ma Xuejun, received a notice from the CSRC regarding the initiation of an investigation for suspected information disclosure violations [1][16]. - The company stated that its business operations are currently normal and that it will actively cooperate during the investigation [1][17]. Group 2: Financial Performance - For the first three quarters of 2025, the company reported a revenue of 552 million yuan, a year-on-year decrease of 34.07%, and a net loss attributable to shareholders of 65.63 million yuan, a decline of 600.98% [11][25]. - As of June 30, 2025, the company had an undistributed profit loss of 41.20 million yuan, with total paid-in capital of 85.95 million yuan, indicating that the unremedied losses exceeded one-third of the total paid-in capital [11][25]. Group 3: Shareholder Actions - One month prior to the investigation notice, Ma Xuejun sold 2.55 million shares, representing 2.97% of the company's total shares, for approximately 64.71 million yuan, citing personal funding needs as the reason for the sale [4][5][20]. - In contrast, another major shareholder, Wang Qiaoqing, chose to terminate a planned share reduction just a week before the investigation notice, expressing confidence in the company's long-term development [6][20]. Group 4: Legal Challenges - The company is also involved in a patent infringement lawsuit filed by Da Dong Electric Industry Co., Ltd., which seeks to stop the production and sale of certain products and claims damages of 10 million yuan [1][17]. - The company indicated that the products in question are not core to its recent offerings and does not expect significant impact on its daily operations [1][17]. Group 5: Governance and Internal Control Issues - The company has faced scrutiny over internal control issues and financial mismanagement, with previous reports indicating that the actual controller had occupied company funds totaling 85.93 million yuan, significantly higher than previously disclosed [12][26]. - The company has received multiple regulatory letters due to these financial issues and has been under continuous scrutiny for its annual report disclosures over the past three years [14][26].

Core Viewpoint - The financial turmoil surrounding the "Xiangyuan system" continues, with the actual controller Yu Faxiang facing criminal charges, negatively impacting the stock prices of Xiangyuan Cultural Tourism, Jiaojian Co., and Haichang Ocean Park. Despite a slight recovery in stock prices on December 24, the core risks remain unresolved [2][3][4]. Group 1: Stock Price Movements - On December 22, the three companies announced that Yu Faxiang was taken into criminal custody, leading to significant stock declines: Xiangyuan Cultural Tourism down 2.80%, Jiaojian Co. down 4.89%, and Haichang Ocean Park down 7.29% on December 23 [3]. - In December, the stock prices of Haichang Ocean Park, Xiangyuan Cultural Tourism, and Jiaojian Co. fell by 35.71%, 19.89%, and 37.09%, respectively [4]. - On December 24, there was a slight recovery in stock prices, with Xiangyuan Cultural Tourism closing at 5.92 yuan (up 0.17%), Jiaojian Co. at 7.65 yuan (up 0.92%), and Haichang Ocean Park at 0.450 HKD (up 1.12%) [4]. Group 2: Financial Product Defaults - Since November 28, multiple financial products guaranteed by Xiangyuan Holdings and Yu Faxiang have faced payment defaults, with over 200 products involved and a total outstanding amount exceeding 200 billion yuan [3][5]. - The financial products are primarily backed by receivables from real estate and cultural tourism projects within the Xiangyuan Holdings system, with guarantees provided by Yu Faxiang [5]. Group 3: Legal and Operational Implications - The involvement of Yu Faxiang in criminal activities is closely linked to the payment defaults of financial products, as he holds significant legal responsibility [5][6]. - There are ongoing concerns regarding the operational status of various projects under the Xiangyuan system, with reports of halted or delayed construction [6]. - The companies have stated that their operations are not affected by the ongoing investigations, and they have not received any notifications regarding cooperation in investigations [7][8]. Group 4: Investor Sentiment and Future Risks - Investor sentiment remains cautious, with concerns about potential fund misappropriation and the overall financial health of the companies [8]. - The companies have previously faced penalties for failing to disclose non-operational fund misappropriation, which has heightened investor anxiety [8]. - The core risks for the companies include the impact of Yu Faxiang's legal issues, potential asset freezes, stock price volatility, and investor rights protection [7][8].

Core Viewpoint - Long Pharmaceutical Holdings (长药控股) is facing legal actions due to allegations of false financial reporting and significant financial irregularities, with ongoing investor compensation claims being processed through the courts [1][3]. Group 1: Legal Proceedings - The law firm Shanghai Jucheng has submitted multiple claims to the Wuhan Intermediate People's Court on behalf of investors against Long Pharmaceutical Holdings, with previous successful cases serving as a precedent [1][3]. - The firm continues to accept claims from other investors who have suffered losses related to the company's stock [3]. Group 2: Financial Irregularities - Long Pharmaceutical Holdings announced on April 30, 2024, that it is under scrutiny for fund misappropriation and illegal guarantees, with an audit report highlighting significant uncertainties regarding its ongoing operations [4]. - The company reported a fund misappropriation amounting to 179,662,019.54 yuan, which represents 92.08% of its most recent audited net assets [4]. Group 3: Investor Compensation - Investors who purchased Long Pharmaceutical Holdings stock between March 30, 2019, and April 30, 2024, and sold or held their shares after April 30, 2024, are eligible to file for compensation based on previous successful judgments [5].

Core Viewpoint - Regulatory authorities have issued administrative penalties to four listed companies, emphasizing a strong stance against financial fraud and violations, regardless of the methods used or the amounts involved [2] Group 1: Company-Specific Violations - Far East Intelligent (ST远智) engaged in financial misconduct by using forged acceptance certificates to prematurely recognize revenue from elevator sales, resulting in inflated revenues of approximately 123 million yuan, 66.23 million yuan, and 138 million yuan from 2019 to 2021 [3][4] - Fuhua Oriental (福能东方) was involved in a scheme with its subsidiary, where it falsely recognized receivables and inflated profits by 35.8 million yuan in 2020, which accounted for 120.18% of the company's reported profit for that year [4][5] - Guizhou Bailin (贵州百灵) failed to adhere to accounting standards, leading to a misstatement of sales expenses and inflated profits by 350 million yuan in 2019 and 240 million yuan in 2020, among other discrepancies [7][8] - Bayi Steel (八一钢铁) was found to have significant non-operating fund transactions with its controlling shareholder, failing to disclose approximately 3.675 billion yuan in transfers in 2022 alone [9] Group 2: Regulatory Actions and Penalties - Far East Intelligent received a warning and a fine of 6 million yuan, with penalties imposed on its executives ranging from 200,000 to 3 million yuan [4] - Fuhua Oriental was fined 6.5 million yuan and received a warning, with its stock facing additional risk warnings due to the violations [5][6] - Guizhou Bailin faced a fine of 10 million yuan, and its chairman is subject to a 10-year ban from the securities market due to severe violations [7][8] - Bayi Steel was fined 3 million yuan, while its controlling shareholder was fined 4 million yuan for failing to disclose significant financial transactions [9]

Core Viewpoint - The ongoing investor compensation case against Changyao Holdings (300391) is driven by allegations of false statements, with a precedent of investor victories in similar claims [1][2][3] Group 1: Legal Proceedings - Changyao Holdings has received a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation into false financial reporting, leading to a formal case being opened [3] - The law firm Shanghai Jiucheng has filed a compensation case on behalf of investors with the Wuhan Intermediate People's Court, awaiting further court arrangements [1][2] - Investors who purchased Changyao Holdings stock between March 30, 2019, and April 30, 2024, and sold or held the stock after April 30, 2024, are eligible to initiate compensation claims [2][4] Group 2: Financial Issues - Changyao Holdings reported a significant fund occupation amounting to 179,662,019.54 yuan, which represents 92.08% of the company's most recent audited net assets [4] - The company plans to clear the occupied funds through the transfer of debts and credits with related parties [4] - An audit report from Zhongshun Yatai Accounting Firm highlighted major uncertainties regarding the company's ongoing operations, indicating serious financial concerns [3]

Core Viewpoint - Jiangsu Wuzhong (SH600200) has been ordered to delist due to years of financial fraud, with its stock price plummeting over 70% since the announcement of its delisting period [1][3]. Group 1: Financial Fraud Details - Over the past four years, Jiangsu Wuzhong's chairman Qian Qunshan and vice-chairman Qian Qunying created a network of related transactions through at least six companies, inflating revenue by over 1.7 billion yuan [3][5]. - The China Securities Regulatory Commission (CSRC) found that three subsidiaries of Jiangsu Wuzhong engaged in non-commercial trade activities with related companies, leading to inflated revenue, operating costs, and profits [5][9]. - The inflated revenue figures for Jiangsu Wuzhong from 2020 to 2023 were 495 million yuan, 469 million yuan, 431 million yuan, and 377 million yuan respectively [9]. Group 2: Company Operations and Investigations - Investigations revealed that four out of five related companies had non-existent registered addresses, indicating potential fraudulent activities [5][7]. - Jiangsu Wuzhong's related parties occupied a total of 769 million yuan in funds, with significant amounts attributed to companies like Zhejiang Unode and Hangzhou Xintong [6][10]. - The company’s trade business was primarily conducted with entities that had questionable legitimacy, contributing billions in revenue while being linked to the fraudulent activities [10][11]. Group 3: Management Response and Accountability - During a shareholder meeting, management was questioned about a sudden cash flow drop of nearly 1 billion yuan, but responses were evasive [12]. - Qian Qunshan claimed he was not involved in the fraudulent trade activities, while other board members provided conflicting statements regarding their knowledge and involvement [13][14]. - The company’s stock price had previously surged due to the success of its medical beauty product, but the ongoing fraud has left investors with significant losses [15][16].